Literature DB >> 3525764

Dose-response is alive and well.

V T DeVita.   

Abstract

Mesh:

Year:  1986        PMID: 3525764     DOI: 10.1200/JCO.1986.4.8.1157

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

Review 1.  Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.

Authors:  W E Evans; M V Relling
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

Review 2.  Optimizing the effectiveness of hematopoietic growth factors.

Authors:  D E Williams
Journal:  J Clin Immunol       Date:  1994-07       Impact factor: 8.317

Review 3.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

4.  Interaction of 5'-deoxy-5-fluorouridine and methotrexate. A basis for reduced methotrexate toxicity.

Authors:  D Bowen; T J Robbins; R M White
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

Review 5.  The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.

Authors:  E K Rowinsky
Journal:  Drugs       Date:  2000       Impact factor: 9.546

6.  Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.

Authors:  Y Humblet; P Weynants; A Bosly; F Majois; P Duprez; C Francis; M Beauduin; J Machiels; C Gailly; L Delaunois
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

Review 7.  Pharmacokinetic optimisation of anticancer therapy.

Authors:  J Liliemark; C Peterson
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

8.  Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.

Authors:  W P Steward; J Verweij; R Somers; G Blackledge; M Clavel; A T Van Oosterom; B Greifenberg; J Soedirman; D Thomas; M Van Glabbeke
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 9.  Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity.

Authors:  W E Evans
Journal:  Blut       Date:  1988-06

10.  5-Fluorouracil (FU) with folinic acid (FA) and mitomycin C (MMC) in the adjuvant treatment of colorectal carcinoma. Part I. Evaluation of toxicity.

Authors:  F Franchi; C Barone; E Ricevuto; A Cassano; A Astone; C Pozzo; L Sofo; G Netri; C Ratto; C Coco
Journal:  Med Oncol Tumor Pharmacother       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.